z-logo
Premium
Platelet changes after a saturated fat meal and their prevention by dazmegrel, a thromboxane synthetase inhibitor
Author(s) -
Belch J. J. F.,
Saniabadi A. R.,
McLaughlin K.,
Forbes C. D.
Publication year - 1987
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/bf02537296
Subject(s) - antithrombotic , meal , platelet , lipidology , medicine , platelet activation , clinical chemistry , thromboxane , endocrinology , chemistry
A saturated fat meal was given to 10 normal males both before and after pretreatment with UK38,485, a thromboxane synthetase inhibitor (Dazmegrel, Pfizer Central Research, Sandwich, Kent, United Kingdom). Following the fat meal at 2 and 4 hr there was laboratory evidence of platelet activation. Dazmegrel lowered baseline platelet activity and lessened platelet activation following the fat meal. This drug should be investigated further as a potential antithrombotic agent.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom